Diabetes and cardiovascular disease.
Neil
Andrew
A
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, The Churchill Hospital, Oxford, UK. andrew.neil@public-health.oxford.ac.uk
D017281:Cost of Illness; D003924:Diabetes Mellitus, Type 2 / Q000401:mortality / Q000517:prevention & control*; D003925:Diabetic Angiopathies / Q000401:mortality / Q000517:prevention & control*; D004338:Drug Combinations; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006943:Hyperglycemia / Q000517:prevention & control; D006949:Hyperlipidemias / Q000517:prevention & control; D006973:Hypertension / Q000517:prevention & control; D007333:Insulin Resistance; D009017:Morbidity; D012307:Risk Factors
D004338:Drug Combinations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors